A study finds that Zoll's LifeVest wearable defibrillator shows promise as a temporary option for patients who must have their ICD removed due to infection and await a new implant.
A new study in the journal Heart Rhythm shows the utility of Zoll Medical's LifeVest wearable defibrillator for a subset of patients who don't start out with the device.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1xJA2Vv
Cap comentari:
Publica un comentari a l'entrada